Back to Search Start Over

TDP2 is a regulator of estrogen-responsive oncogene expression.

Authors :
Manguso N
Kim M
Joshi N
Al Mahmud MR
Aldaco J
Suzuki R
Cortes-Ledesma F
Cui X
Yamada S
Takeda S
Giuliano A
You S
Tanaka H
Source :
NAR cancer [NAR Cancer] 2024 Apr 08; Vol. 6 (2), pp. zcae016. Date of Electronic Publication: 2024 Apr 08 (Print Publication: 2024).
Publication Year :
2024

Abstract

With its ligand estrogen, the estrogen receptor (ER) initiates a global transcriptional program, promoting cell growth. This process involves topoisomerase 2 (TOP2), a key protein in resolving topological issues during transcription by cleaving a DNA duplex, passing another duplex through the break, and repairing the break. Recent studies revealed the involvement of various DNA repair proteins in the repair of TOP2-induced breaks, suggesting potential alternative repair pathways in cases where TOP2 is halted after cleavage. However, the contribution of these proteins in ER-induced transcriptional regulation remains unclear. We investigated the role of tyrosyl-DNA phosphodiesterase 2 (TDP2), an enzyme for the removal of halted TOP2 from the DNA ends, in the estrogen-induced transcriptome using both targeted and global transcription analyses. MYC activation by estrogen, a TOP2-dependent and transient event, became prolonged in the absence of TDP2 in both TDP2-deficient cells and mice. Bulk and single-cell RNA-seq analyses defined MYC and CCND1 as oncogenes whose estrogen response is tightly regulated by TDP2. These results suggest that TDP2 may inherently participate in the repair of estrogen-induced breaks at specific genomic loci, exerting precise control over oncogenic gene expression.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of NAR Cancer.)

Details

Language :
English
ISSN :
2632-8674
Volume :
6
Issue :
2
Database :
MEDLINE
Journal :
NAR cancer
Publication Type :
Academic Journal
Accession number :
38596431
Full Text :
https://doi.org/10.1093/narcan/zcae016